Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Jazz Pharmaceuticals plc
- BioAge Labs, Inc.
- Vera Therapeutics, Inc.
- Zenas BioPharma, Inc.
Updated Jul 16, 2026
ENRIGHT PATRICK G has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $25.80M. Historical track record: 4/5 stars across 8 tracked purchases.
| Role | Director |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★☆ (4/5) |
|---|---|
| Total purchases tracked | 8 |
| Purchases with forward-return data | 8 |
| 30-day win rate | 7500% |
| 90-day win rate | 7500% |
| Avg 5-day return | +378.39% |
| Avg 30-day return | +1412.47% |
| Avg 90-day return | +4777.65% |
| Best 30-day return | +3810.55% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-06 | MANE | Veradermics, Inc | P — Open-market purchase | 882.4K | $17.00 | $15.00M |
| 2026-02-06 | MANE | Veradermics, Inc | P — Open-market purchase | 192.6K | $17.00 | $3.27M |
| 2026-02-06 | MANE | Veradermics, Inc | J — Other acquisition / disposition | 1.17M | — | |
| 2026-02-06 | MANE | Veradermics, Inc | J — Other acquisition / disposition | 1.17M | — | |
| 2026-02-06 | MANE | Veradermics, Inc | J — Other acquisition / disposition | 1.24M | — | |
| 2025-10-09 | ZBIO | Zenas BioPharma, Inc. | P — Open-market purchase | 12.0K | $20.85 | $250K |
| 2025-10-09 | ZBIO | Zenas BioPharma, Inc. | P — Open-market purchase | 105.3K | $19.00 | $2.00M |
| 2025-08-07 | JAZZ | Jazz Pharmaceuticals plc | F — Tax withholding / forfeiture | 1.8K | $111.25 | $201K |
| 2025-08-07 | JAZZ | Jazz Pharmaceuticals plc | A — Grant or award | 3.5K | $0.00 | |
| 2025-06-23 | VERA | Vera Therapeutics, Inc. | P — Open-market purchase | 27.1K | $22.35 | $605K |
| 2025-06-23 | VERA | Vera Therapeutics, Inc. | P — Open-market purchase | 13.5K | $22.35 | $303K |
| 2025-06-23 | VERA | Vera Therapeutics, Inc. | P — Open-market purchase | 139.6K | $20.87 | $2.91M |
| 2025-06-23 | VERA | Vera Therapeutics, Inc. | P — Open-market purchase | 69.8K | $20.87 | $1.46M |
ENRIGHT PATRICK G is a corporate insider — currently tracked as Director of Zenas BioPharma, Inc. (ZBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 8 open-market purchases ($25.80M) and 0 open-market sales () across all tracked filings.
Across 8 tracked purchases, ENRIGHT PATRICK G averaged +1412.5% avg 30-day return with a 7500% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live ENRIGHT PATRICK G profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.